Drug Database
Back to search

United Kingdom· GB-APID-4419111000001106

Trizivir 300mg/150mg/300mg tablets

A zidovudine, lamivudine and abacavir product containing abacavir + lamivudine + zidovudine, registered in United Kingdom by ViiV Healthcare UK Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC J05AR04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTrizivir 300mg/150mg/300mg tabletsATCJ05AR04REGISTER NO.GB-APID-4419111000001…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about abacavir + lamivudine + zidovudineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zidovudine, lamivudine and abacavir is registered in 10 of 19 countries.

Countries holding a registration under ATC J05AR04 (zidovudine, lamivudine and abacavir), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 6 of them publish a price we can compare per daily dose
Search zidovudine, lamivudine and abacavir products by name

Zidovudine, lamivudine and abacavir · ATC J05AR04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Abacavir + Lamivudine + Zidovudine
Manufacturer
ViiV Healthcare UK Ltd
Country
United Kingdom (GB)
ATC code
J05AR04
ATC class
Zidovudine, lamivudine and abacavir
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5000123110247

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for zidovudine, lamivudine and abacavir.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check zidovudine, lamivudine and abacavir against other medicinesHow interaction checks work

Zidovudine, lamivudine and abacavir · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Zidovudine, lamivudine and abacavir in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zidovudine, lamivudine and abacavir products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • France · Abacavir/Lamivudine/Zidovudine Viatris
  • Iceland · Trizivir
  • Italy · Abacavir/Lamivudina/Zidovudina Mylan
  • Liechtenstein · Trizivir
  • Netherlands · Abacavir/Lamivudine/Zidovudine Mylan
  • Norway · Trizivir

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8a0f787-8126-4026-badc-e5d7c5eeda3e
GET /v1/drugs/f8a0f787-8126-4026-badc-e5d7c5eeda3e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4419111000001106",
  "desc": "Trizivir 300mg/150mg/300mg tablets (ViiV Healthcare UK Ltd)",
  "form": "Oral tablet",
  "vpid": "4435711000001101",
  "source": "dmd",
  "vtm_id": "772197002",
  "strength": "300 mg",
  "substance": "Abacavir + Lamivudine + Zidovudine",
  "ingredient": "Abacavir sulfate",
  "supplier_code": "16436711000001101"
}
API referenceMCP serverPlans

See everything about zidovudine, lamivudine and abacavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console